Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» March 2014
March 2014
Can Arena and VIVUS Profit From Glaxo's Troubles?
Can Arena and VIVUS Profit From Glaxo's Troubles?
Motley Fool
Arena Pharmaceuticals
Vivus
GSK
Alli
tampering
U.S. judge upholds validity of Eli Lilly's Alimta patent
U.S. judge upholds validity of Eli Lilly's Alimta patent
Yahoo/Reuters
Eli Lilly
Alimta
patents
GSK building up R&D, manufacturing and goodwill in Africa
GSK building up R&D, manufacturing and goodwill in Africa
Fierce Pharma
R&D
GSK
Africa
Biogen hemophilia nod puts Baxter's to-be-spun-off biopharma unit on notice
Biogen hemophilia nod puts Baxter's to-be-spun-off biopharma unit on notice
Fierce Pharma
hemophilia B
Biogen Idec
Baxter International
Alprolix
Durata's anti-infective drug shows efficacy, safety -FDA panel
Durata's anti-infective drug shows efficacy, safety -FDA panel
Yahoo/Zacks.com
Durata
FDA
advisory panels
dalbavancin
Does Arena Pharmaceuticals Have An Anti-Smoking Opportunity?
Does Arena Pharmaceuticals Have An Anti-Smoking Opportunity?
Motley Fool
Arena Pharmaceuticals
smoking cessation
Belviq
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Yahoo/Benzinga
FDA
MannKind
Afrezza
Glaxo scraps the ovarian cancer app for Votrient
Glaxo scraps the ovarian cancer app for Votrient
Fierce Biotech
Europe
GSK
ovarian cancer
Votrient
Sanofi aims for outcomes with brand-new Chief Patient Officer
Sanofi aims for outcomes with brand-new Chief Patient Officer
Fierce Pharma Marketing
Sanofi
patient outcomes
FDA panel says Cubist anti-infective shows efficacy, safety
FDA panel says Cubist anti-infective shows efficacy, safety
Yahoo/Reuters
FDA
Cubist Pharmaceuticals
antibiotics
tedizolid
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »